Ogilvie syndrome risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ogilvie syndrome}} | |||
{{CMG}}; {{AE}} {{AEL}} | |||
==Overview== | ==Overview== | ||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors for Ogilvie's syndrome include the following:<ref name="AoS">[http://archsurg.ama-assn.org/cgi/content/abstract/135/6/682 Ogilvie Syndrome as a Postoperative Complication] Patty L. Tenofsky, MD; R. Larry Beamer, MD; R. Stephen Smith, MD [http://archsurg.ama-assn.org/ Arch Surg.] 2000;135:682-687.</ref><ref name="pmid28257284">{{cite journal| author=Sreter KB, Barisic B, Popovic-Grle S| title=Pharmacogenomics and tailored polypharmacy: an 80-year-old lady with rosuvastatin-associated rhabdomyolysis and maprotiline-related Ogilvie's syndrome
. | journal=Int J Clin Pharmacol Ther | year= 2017 | volume= 55 | issue= 5 | pages= 442-448 | pmid=28257284 | doi=10.5414/CP202784 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28257284 }}</ref> | Common risk factors for Ogilvie's syndrome include the following:<ref name="AoS">[http://archsurg.ama-assn.org/cgi/content/abstract/135/6/682 Ogilvie Syndrome as a Postoperative Complication] Patty L. Tenofsky, MD; R. Larry Beamer, MD; R. Stephen Smith, MD [http://archsurg.ama-assn.org/ Arch Surg.] 2000;135:682-687.</ref><ref name="pmid28257284">{{cite journal| author=Sreter KB, Barisic B, Popovic-Grle S| title=Pharmacogenomics and tailored polypharmacy: an 80-year-old lady with rosuvastatin-associated rhabdomyolysis and maprotiline-related Ogilvie's syndrome
. | journal=Int J Clin Pharmacol Ther | year= 2017 | volume= 55 | issue= 5 | pages= 442-448 | pmid=28257284 | doi=10.5414/CP202784 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28257284 }}</ref> | ||
Revision as of 15:15, 7 February 2018
| Ogilvie syndrome Microchapters
|
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ogilvie syndrome risk factors On the Web |
|
American Roentgen Ray Society Images of Ogilvie syndrome risk factors |
|
Risk calculators and risk factors for Ogilvie syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Risk Factors
Common risk factors for Ogilvie's syndrome include the following:[1][2]
- Having cerebral palsy or other nervous system (neurologic) disorders
- Staying in bed for long periods of time
- Taking narcotic medications
- Trauma
- Cardiac diseases as myocardial infarction
Less common risk factors for Ogilvie's syndrome include the following:[3]
- Systemic lupus erythematosus
- Alcoholism
- Multiple myeloma
- Systemic sclerosis
References
- ↑ Ogilvie Syndrome as a Postoperative Complication Patty L. Tenofsky, MD; R. Larry Beamer, MD; R. Stephen Smith, MD Arch Surg. 2000;135:682-687.
- ↑ Sreter KB, Barisic B, Popovic-Grle S (2017). "Pharmacogenomics and tailored polypharmacy: an 80-year-old lady with rosuvastatin-associated rhabdomyolysis and maprotiline-related Ogilvie's syndrome". Int J Clin Pharmacol Ther. 55 (5): 442–448. doi:10.5414/CP202784. PMID 28257284.
- ↑ García López CA, Laredo-Sánchez F, Malagón-Rangel J, Flores-Padilla MG, Nellen-Hummel H (2014). "Intestinal pseudo-obstruction in patients with systemic lupus erythematosus: a real diagnostic challenge". World J Gastroenterol. 20 (32): 11443–50. doi:10.3748/wjg.v20.i32.11443. PMC 4145788. PMID 25170234.